Gynäkologische Tumore | Medizin im Gespräch

https://www.leopoldina-krankenhaus.co... Prof. Dr. Michael Weigel is the Chief Physician of the Department of Gynecology and Obstetrics at the Leopoldina Hospital in Schweinfurt. He also heads the Schweinfurt-Mainfranken Breast Center and the Gynecological Cancer Center at the Leopoldina Hospital. He provides a brief overview of what falls under the category of gynecological tumors and the available treatment options. Generally speaking, gynecological tumors encompass all growths of the female genitalia, from the labia to the ovaries. Cancer of the fallopian tubes and ovaries is among the most troublesome. These structures lie freely within the abdominal cavity, allowing a tumor to spread very easily. Furthermore, this type of cancer is not always detected during routine gynecological checkups. An experienced clinic can often cure this disease through extensive surgery followed by chemo-immunotherapy. In Germany, most women develop endometrial cancer, followed by fallopian tube and ovarian cancer. Cervical cancer, once very common, has declined significantly due to successful preventative care and early detection. Recently, there has been a rise in vaginal cancer, even among women under 50. This cancer is caused by a virus. In most women, the infection clears up on its own. However, smoking, in particular, can lead to the development of cancer over the years, which is not always easily detected with a Pap smear and can sometimes be missed. If vaginal cancer develops, it must be surgically removed. If it is already advanced, the shape of the vaginal opening can be restored with plastic surgery. Risk factors for developing cancer include smoking, obesity, type 2 diabetes, and genetic predisposition. Vaccination could prevent 90% of virus-induced cancers. Therefore, vaccination is recommended for girls between the ages of 9 and 14. However, preventative screenings can also detect and treat precancerous lesions in their early stages. Every woman is entitled to a preventative screening at least once a year.